This study identifies QPCT, ARHGEF37, FLNC, and LGALS7 as four key proteins that are abnormally upregulated in BPH and potentially involved in the activation of the MAPK signaling pathway. This evidence concerns the gene FLNC and benign prostatic hyperplasia.